Aspiriant LLC’s Vanguard FTSE All-World ex-US ETF VEU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25M Sell
332,975
-82
-0% -$6.35K 0.71% 23
2025
Q4
$24.5M Buy
333,057
+4,807
+1% +$350K 0.7% 23
2025
Q3
$23.4M Buy
328,250
+458
+0.1% +$31.6K 0.72% 23
2025
Q2
$22M Buy
327,792
+3,048
+0.9% +$193K 0.7% 24
2025
Q1
$19.7M Buy
324,744
+2,872
+0.9% +$173K 0.68% 21
2024
Q4
$18.5M Sell
321,872
-2,649
-0.8% -$160K 0.67% 23
2024
Q3
$20.4M Buy
324,521
+223
+0.1% +$13.4K 0.78% 21
2024
Q2
$19M Sell
324,298
-1,671
-0.5% -$98K 0.78% 24
2024
Q1
$19.1M Buy
325,969
+2,836
+0.9% +$160K 0.79% 23
2023
Q4
$18.1M Buy
323,133
+4,816
+2% +$255K 0.82% 23
2023
Q3
$16.5M Sell
318,317
-2,446
-0.8% -$132K 0.84% 20
2023
Q2
$17.5M Buy
320,763
+2,503
+0.8% +$136K 0.88% 19
2023
Q1
$17M Sell
318,260
-1,527
-0.5% -$80.9K 0.89% 19
2022
Q4
$16M Buy
319,787
+798
+0.3% +$38.7K 0.82% 20
2022
Q3
$14.2M Sell
318,989
-6,475
-2% -$320K 0.69% 25
2022
Q2
$16.3M Buy
325,464
+730
+0.2% +$39.1K 0.79% 22
2022
Q1
$18.7M Sell
324,734
-10,661
-3% -$627K 1.03% 17
2021
Q4
$20.6M Buy
335,395
+6,688
+2% +$414K 1.1% 17
2021
Q3
$20M Sell
328,707
-1,057
-0.3% -$66.5K 1.18% 15
2021
Q2
$20.9M Sell
329,764
-3,784
-1% -$239K 1.18% 16
2021
Q1
$20.2M Buy
333,548
+5,205
+2% +$317K 1.29% 16
2020
Q4
$19.2M Buy
328,343
+8,032
+3% +$438K 1.31% 15
2020
Q3
$16.2M Buy
320,311
+59,121
+23% +$3M 1.26% 16
2020
Q2
$12.4M Sell
261,190
-4,241
-2% -$190K 1.15% 17
2020
Q1
$10.9M Buy
265,431
+20,687
+8% +$1.02M 1.07% 19
2019
Q4
$13.2M Sell
244,744
-10,323
-4% -$536K 1.22% 18
2019
Q3
$12.7M Buy
255,067
+4,455
+2% +$222K 1.14% 20
2019
Q2
$12.8M Sell
250,612
-8,654
-3% -$437K 1.07% 20
2019
Q1
$13M Sell
259,266
-105,607
-29% -$5.17M 1.06% 22
2018
Q4
$16.6M Buy
364,873
+12,663
+4% +$608K 1.26% 21
2018
Q3
$18.3M Buy
352,210
+2,823
+0.8% +$147K 1.57% 17
2018
Q2
$18.1M Sell
349,387
-12,197
-3% -$661K 1.55% 17
2018
Q1
$19.7M Buy
361,584
+150,715
+71% +$8.4M 1.71% 18
2017
Q4
$11.5M Sell
210,869
-195,357
-48% -$10.5M 3.39% 11
2017
Q3
$21.4M Sell
406,226
-12,545
-3% -$649K 1.79% 16
2017
Q2
$21M Sell
418,771
-41,351
-9% -$2.05M 1.82% 15
2017
Q1
$22M Sell
460,122
-14,457
-3% -$674K 1.87% 15
2016
Q4
$21M Sell
474,579
-30,646
-6% -$1.36M 1.9% 16
2016
Q3
$23M Sell
505,225
-65,140
-11% -$2.91M 2.28% 11
2016
Q2
$24.5M Sell
570,365
-112,089
-16% -$4.86M 2.31% 11
2016
Q1
$29.4M Sell
682,454
-120,055
-15% -$4.92M 2.81% 9
2015
Q4
$34.8M Sell
802,509
-912,343
-53% -$40.8M 3.83% 11
2015
Q3
$80M Buy
1,714,852
+543,227
+46% +$25.1M 6.65% 4
2015
Q2
$56.9M Buy
1,171,625
+570,167
+95% +$28.9M 5.55% 7
2015
Q1
$29.3M Sell
601,458
-41,067
-6% -$1.97M 3.8% 9
2014
Q4
$30.1M Sell
642,525
-2,188
-0.3% -$105K 4.03% 8
2014
Q3
$31.7M Sell
644,713
-9,588
-1% -$496K 4.43% 8
2014
Q2
$34.2M Sell
654,301
-23,134
-3% -$1.19M 4.71% 7
2014
Q1
$34.1M Sell
677,435
-7,089
-1% -$351K 4.94% 7
2013
Q4
$34.7M Sell
684,524
-7,150
-1% -$356K 5.41% 6
2013
Q3
$33.6M Sell
691,674
-8,135
-1% -$382K 6.02% 7
2013
Q2
$30.9M Buy
+699,809
New +$32.7M 4.86% 7

Other funds holding VEU

Aspiriant LLC's VEU Position: Q1 2026 in Review

Aspiriant LLC reduced its Vanguard FTSE All-World ex-US ETF (VEU) stake by 0.02% in Q1 2026, selling an estimated $6.35K and leaving 332,975 shares worth $25M. The position accounts for 0.71% of the portfolio, ranked #23.

Aspiriant LLC first reported a position in VEU in Q2 2013 and has held it in 52 quarters since. The position peaked at $80M in Q3 2015. 1,559 funds tracked by Wall St. Rank hold VEU as of Q1 2026.

  • Aspiriant LLC held 332,975 shares of Vanguard FTSE All-World ex-US ETF worth $25M as of Q1 2026.
  • Aspiriant LLC sold 82 Vanguard FTSE All-World ex-US ETF shares in Q1 2026, an estimated $6.35K.
  • Vanguard FTSE All-World ex-US ETF made up 0.71% of Aspiriant LLC's portfolio in Q1 2026, its #23 holding.
  • Aspiriant LLC first reported a position in Vanguard FTSE All-World ex-US ETF in Q2 2013 and has held it in 52 quarters since.
  • Aspiriant LLC's Vanguard FTSE All-World ex-US ETF position peaked at $80M in Q3 2015.
  • 1,559 funds tracked by Wall St. Rank held Vanguard FTSE All-World ex-US ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.